CD1d remodels the tumor-infiltrating myeloid populations controlling antitumor immunity
CD1d targeting reshapes tumor immune infiltrates, suppresses tumor growth, and enhances immunotherapy efficacy, suggesting an actionable pathway for therapeutic intervention.